Stocktoria

CytomX Therapeutics, Inc. CTMX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-10-08 · LEI

CytomX Therapeutics, Inc. statistics & valuation

Market cap$740.2M
P / S9.7×
P / B7.5×
Net margin-22.8%
Return on equity-17.5%
FCF margin-99.5%
Return on capital-21.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-391.50% -60.20% -142.20% -177.80% -32.80% -310.50% -186.80% -0.60% 23.10% -22.80% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-396.10% -64.60% -130.90% -192.90% -48.40% -311.00% -190.60% -6.40% 18.10% -29.30% 2016201720182019202020212022202320242025
Return on equity (%)
-75.10% -61.70% -64.60% -200.00% -17.50% 2016201720182019202020212022202320242025
Shares outstanding
36.5M 38.5M 45.1M 45.5M 48.3M 65.4M 66.2M 73.8M 84.7M 170.2M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-29.60% -10.80% -18.50% -30.00% -9.20% -34.10% -38.10% -0.30% 26.40% -11.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-28.00% 235.70% -133.30% -250.40% 2.90% -323.30% -211.70% -56.20% -62.70% -99.50% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-29.3%18.1%-6.4%-190.6%-311.0%-48.4%-192.9%-130.9%-64.6%-396.1%
Net margin-22.8%23.1%-0.6%-186.8%-310.5%-32.8%-177.8%-142.2%-60.2%-391.5%
FCF margin-99.5%-62.7%-56.2%-211.7%-323.3%2.9%-250.4%-133.3%235.7%-28.0%
Return on assets-11.5%26.4%-0.3%-38.1%-34.1%-9.2%-30.0%-18.5%-10.8%-29.6%
Return on equity-17.5%-6988.8%1.2%115.8%25244.0%423.0%-200.0%-64.6%-61.7%-75.1%
Current ratio3.091.251.171.553.983.213.544.556.365.26

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.